The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults

Previous studies have indicated that physical activity may be beneficial in reducing the risk for Alzheimer's disease (AD), although the underlying mechanisms are not fully understood. The goal of this study was to evaluate the relationship between habitual physical activity levels and brain amyloid deposition and AD-related blood biomarkers (i.e., measured using a novel high-performance mass spectrometry-based assay), in apolipoprotein E (APOE) epsilon 4 carriers and noncarriers. We evaluated 143 cognitively normal older adults, all of whom had brain amyloid deposition assessed using positron emission tomography and had their physical activity levels measured using the International Physical Activity Questionnaire (IPAQ). We observed an inverse correlation between brain amyloidosis and plasma beta-amyloid (A beta)(1-42) but found no association between brain amyloid and plasma A beta(1-40) and amyloid precursor protein (APP)(669-711). Additionally, higher levels of physical activity were associated with lower plasma A beta(1-40), A beta(1-42), and APP(669-711) levels in APOE epsilon 4 noncarriers. The ratios of A beta(1-40)/A beta(1-42) and APP(669-711)/A beta(1-42), which have been associated with higher brain amyloidosis in previous studies, differed between APOE epsilon 4 carriers and non-carriers. Taken together, these data indicate a complex relationship between physical activity and brain amyloid deposition and potential blood-based AD biomarkers in cognitively normal older adults. In addition, the role of APOE epsilon 4 is still unclear, and more studies are necessary to bring further clarification.

Automated summary

This study aimed to evaluate the relationship between habitual physical activity levels and brain amyloid deposition and AD-related blood biomarkers. The results showed that higher levels of physical activity were associated with lower brain amyloid deposition and plasma protein levels. There were also differences in the blood biomarker ratios between APOE ε4 carriers and non-carriers.